Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC

INTRODUCTION: In advanced-stage NSCLC, tumor proportion score (TPS) is typically used to predict the efficacy of immune checkpoint inhibitors (ICIs). Nevertheless, in other cancer types, the combined positive score (CPS), which covers programmed death-ligand 1 (PD-L1) expression on both tumor and su...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulas, Ezgi B., Hashemi, Sayed M.S., Houda, Ilias, Kaynak, Adem, Veltman, Joris D., Fransen, Marieke F., Radonic, Teodora, Bahce, Idris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480627/
https://www.ncbi.nlm.nih.gov/pubmed/37681219
http://dx.doi.org/10.1016/j.jtocrr.2023.100532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480627/
https://www.ncbi.nlm.nih.gov/pubmed/37681219
http://dx.doi.org/10.1016/j.jtocrr.2023.100532

Ejemplares similares